Related Experiment Video
Updated: May 14, 2026
07:34
Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique
Published on: December 15, 2023
Emerging molecular targets for brain repair after stroke
1Cerebrovascular Diseases Unit, Department of Neurology, University Hospital Mutua Terrassa, Terrassa, 08221 Barcelona, Spain ; School of Healthcare Science, Manchester Metropolitan University, Manchester M1 5GD, UK.
Stroke Research and Treatment
|February 1, 2013
Summary
Neuroprotection research faces translation challenges. Epigenetic factors, particularly microRNAs, show promise for understanding stroke pathology and developing new treatments.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Preclinical neuroprotection findings have not translated to clinical success.
- Stroke is a complex disease with genetic and epigenetic influences.
- Current therapeutic strategies require further development.
Purpose of the Study:
- To review the challenges in neuroprotection translation.
- To highlight the role of epigenetics in stroke.
- To explore the potential of microRNAs in stroke treatment.
Main Methods:
- Literature review of neuroprotection and stroke research.
- Analysis of genetic and epigenetic factors in stroke.
- Discussion of microRNA mechanisms and therapeutic potential.
Main Results:
- Failure of preclinical neuroprotection to translate clinically.
- Identification of epigenetic factors, including microRNAs, as key players in stroke.
- Recognition of the early stage of epigenetics research in stroke.
Conclusions:
- Combined therapeutic strategies require further research and testing.
- Epigenetic mechanisms, especially microRNAs, offer promising avenues for stroke treatment.
- Advances in genetics and epigenetics enhance understanding of stroke pathology.
